Current use of pimobendan in canine patients with heart disease.

Abstract

Pimobendan is a drug with both inotropic and vasodilatory properties and is widely used for the treatment of heart failure in dogs. The best evidence regarding its efficacy is derived from several clinical studies of dogs with the two most common conditions that result in heart failure: dilated cardiomyopathy (DCM) and degenerative mitral valve disease (DMVD). The main studies addressing the effectiveness of pimobendan in dogs with DCM and DVMD are discussed in this article.

• Authors: Adrian Boswood
• Journal: The Veterinary clinics of North America. Small animal practice (Vet Clin North Am Small Anim Pract) Vol. 40 Issue 4 Pg. 571-80 (Jul 2010) ISSN: 1878-1306 [Electronic] United States
• PMID: 20610012 (Publication Type: Journal Article, Review)

Chemical References

• Cardiotonic Agents
• Pyridazines
• pimobendan

Topics

• Animals
• Cardiomyopathy, Dilated (drug therapy, veterinary)
• Cardiotonic Agents (therapeutic use)
• Dog Diseases (drug therapy)
• Dogs
• Female
• Heart Diseases (drug therapy, veterinary)
• Male
• Mitral Valve Insufficiency
• Pyridazines (therapeutic use)
• Treatment Outcome